Minerva Neurosciences Inc
NASDAQ:NERV
Minerva Neurosciences Inc
NASDAQ:NERV
Price:
5.94
USD
-13.03%
Market Closed
Market Cap:
$257m
Balance Sheet
Balance Sheet Decomposition
Minerva Neurosciences Inc
Minerva Neurosciences Inc
Balance Sheet Decomposition is not available for
Minerva Neurosciences Inc
Minerva Neurosciences Inc
Balance Sheet
Minerva Neurosciences Inc
Minerva Neurosciences Inc
Currency: USD
| Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
2
|
19
|
14
|
83
|
26
|
50
|
21
|
25
|
61
|
36
|
41
|
21
|
|
| Cash Equivalents |
0
|
0
|
2
|
19
|
14
|
83
|
26
|
50
|
21
|
25
|
61
|
36
|
41
|
21
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
18
|
0
|
102
|
38
|
24
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
2
|
1
|
2
|
1
|
4
|
1
|
1
|
|
| Total Current Assets |
0
|
0
|
2
|
19
|
34
|
84
|
130
|
90
|
47
|
27
|
62
|
40
|
42
|
22
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
19
|
34
|
34
|
34
|
34
|
34
|
15
|
15
|
0
|
0
|
0
|
0
|
|
| Goodwill |
0
|
0
|
8
|
15
|
15
|
15
|
15
|
15
|
15
|
15
|
15
|
15
|
15
|
15
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
0
|
8
|
15
|
15
|
15
|
15
|
15
|
15
|
15
|
15
|
15
|
15
|
15
|
|
| Total Assets |
0
N/A
|
0
N/A
|
29
+14 500%
|
69
+135%
|
83
+21%
|
133
+61%
|
184
+38%
|
139
-24%
|
78
-44%
|
58
-26%
|
77
+34%
|
55
-29%
|
57
+3%
|
37
-35%
|
|
| Liabilities | |||||||||||||||
| Accounts Payable |
0
|
0
|
1
|
1
|
1
|
2
|
1
|
2
|
2
|
1
|
2
|
1
|
2
|
2
|
|
| Accrued Liabilities |
0
|
0
|
1
|
3
|
3
|
3
|
1
|
2
|
4
|
2
|
1
|
0
|
2
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
1
|
5
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
1
|
4
|
5
|
10
|
7
|
4
|
7
|
3
|
3
|
1
|
3
|
3
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
9
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
82
|
60
|
|
| Deferred Income Tax |
0
|
0
|
8
|
13
|
13
|
13
|
4
|
4
|
2
|
2
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
41
|
41
|
41
|
0
|
66
|
74
|
82
|
60
|
|
| Total Liabilities |
0
N/A
|
0
+100%
|
9
+4 400%
|
17
+89%
|
27
+61%
|
27
-1%
|
52
+93%
|
49
-6%
|
50
+2%
|
5
-90%
|
69
+1 282%
|
75
+9%
|
85
+14%
|
63
-26%
|
|
| Equity | |||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
13
|
15
|
18
|
75
|
102
|
133
|
164
|
215
|
287
|
285
|
335
|
367
|
397
|
395
|
|
| Additional Paid In Capital |
13
|
15
|
38
|
126
|
157
|
239
|
296
|
305
|
315
|
338
|
343
|
347
|
368
|
370
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
0
N/A
|
0
N/A
|
20
N/A
|
52
+155%
|
55
+7%
|
106
+92%
|
132
+24%
|
90
-31%
|
28
-69%
|
53
+90%
|
8
-85%
|
20
N/A
|
28
-42%
|
26
+10%
|
|
| Total Liabilities & Equity |
0
N/A
|
0
N/A
|
29
+14 500%
|
69
+135%
|
83
+21%
|
133
+61%
|
184
+38%
|
139
-24%
|
78
-44%
|
58
-26%
|
77
+34%
|
55
-29%
|
57
+3%
|
37
-35%
|
|
| Shares Outstanding | |||||||||||||||
| Common Shares Outstanding |
2
|
2
|
2
|
2
|
3
|
4
|
5
|
5
|
5
|
5
|
5
|
5
|
7
|
7
|
|
Switch to:
Switch to:
See Also
Discover More
